Get my drift?
Back in 2008, an excited Pfizer shelled out $40 million upfront and agreed to make a $10 million equity investment in exchange for the worldwide rights to Celldex's CDX-110 (rindopepimut), a promising brain cancer vaccine. But by last September, that therapy no longer fit into Pfizer's new vision of its future, and the Big Pharma company washed its hands of its $440 million deal for the program.
pfizer interest to terminate, page-8
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.10 |
Change
-0.110(0.54%) |
Mkt cap ! $2.569B | |||
| Open | High | Low | Value | Volume |
| $20.16 | $20.21 | $19.88 | $5.839M | 291.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1042 | $20.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.11 | 1092 | 2 |
View Market Depth
| Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |